Your browser doesn't support javascript.
loading
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis.
Zaremba, Anne; Kramer, Rafaela; De Temple, Viola; Bertram, Stefanie; Salzmann, Martin; Gesierich, Anja; Reinhardt, Lydia; Baroudjian, Barouyr; Sachse, Michael M; Mechtersheimer, Gunhild; Johnson, Douglas B; Weppler, Alison M; Spain, Lavinia; Loquai, Carmen; Dudda, Milena; Pföhler, Claudia; Hepner, Adriana; Long, Georgina V; Menzies, Alexander M; Carlino, Matteo S; Lebbé, Céleste; Enokida, Tomohiro; Tahara, Makoto; Bröckelmann, Paul J; Eigentler, Thomas; Kähler, Katharina C; Gutzmer, Ralf; Berking, Carola; Ugurel, Selma; Stadtler, Nadine; Sucker, Antje; Becker, Jürgen C; Livingstone, Elisabeth; Meier, Friedegund; Hassel, Jessica C; Schadendorf, Dirk; Hanoun, Maher; Heinzerling, Lucie; Zimmer, Lisa.
Affiliation
  • Zaremba A; Department of Dermatology, Venerology and Allergology, University Hospital Essen, Essen, Germany.
  • Kramer R; Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • De Temple V; Deutsches Zentrum Immuntherapie (DZI) , Erlangen, Germany.
  • Bertram S; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC ER-EMN), Erlangen, Germany.
  • Salzmann M; Department of Dermatology, Venerology and Allergology, University Hospital Essen, Essen, Germany.
  • Gesierich A; Department of Dermatology, Mühlenkreiskliniken AöR, Ruhr University Bochum, Minden, Germany.
  • Reinhardt L; Institute of Pathology, University Hospital Essen, Essen, Germany.
  • Baroudjian B; Skin Cancer Center, Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital, Heidelberg, Germany.
  • Sachse MM; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
  • Mechtersheimer G; Skin Cancer Center at the University Cancer Centre Dresden and National Center for Tumor Diseases, Dresden, Germany.
  • Johnson DB; Department of Dermatology, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.
  • Weppler AM; Université de Paris, Department of Dermatology, AP-HP Hôpital Saint Louis, INSERM U976, Paris, France.
  • Spain L; Department of Dermatology, Allergology and Phlebology, Bremerhaven Reinkenheide Hospital, Bremerhaven, Germany.
  • Loquai C; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Dudda M; Vanderbilt University Medical Center, Department of Medicine, Division of Hematology and Oncology, Nashville, TN, United States.
  • Pföhler C; Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Hepner A; Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Long GV; Department of Dermatology, University Medical Center, Mainz, Germany.
  • Menzies AM; Department of Dermatology, University Medical Center, Mainz, Germany.
  • Carlino MS; Department of Dermatology, Saarland University Medical Center, Homburg, Germany.
  • Lebbé C; Department of Medical Oncology, Melanoma Institute Australia, Sydney, NSW, Australia.
  • Enokida T; Medical Oncology Service, Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Brazil.
  • Tahara M; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
  • Bröckelmann PJ; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Eigentler T; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
  • Kähler KC; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
  • Gutzmer R; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Berking C; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
  • Ugurel S; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
  • Stadtler N; Westmead and Blacktown Hospitals, Sydney, NSW, Australia.
  • Sucker A; Université de Paris, Department of Dermatology, AP-HP Hôpital Saint Louis, INSERM U976, Paris, France.
  • Becker JC; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Livingstone E; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Meier F; Department I of Internal Medicine, Centre of Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Hassel JC; Department of Dermatology, University Hospital Tübingen, Germany and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Dermatology, Venerology and Allergology, Berlin, Germany.
  • Schadendorf D; German Cancer Consortium (DKTK), Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
  • Hanoun M; Department of Dermatology, University Hospital Schleswig Holstein, Kiel, Germany.
  • Heinzerling L; Department of Dermatology, Mühlenkreiskliniken AöR, Ruhr University Bochum, Minden, Germany.
  • Zimmer L; Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Front Oncol ; 11: 765608, 2021.
Article in En | MEDLINE | ID: mdl-34746007
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2021 Document type: Article Affiliation country: Country of publication: